To our knowledge, the present study is the first to comprehensively evaluate RPL4P4 expression and its association with clinical and prognostic outcomes in glioma using various public databases, including the CGGA, TCGA, GEPA2, and UALCAN datasets. Here, RPL4P4 is linked to central nervous system cancer.